Evidence map›Paper›PMID 40986553›Full record

ArticlePloS one2025

Assessment of environmental risk factors for blastomycosis during a large outbreak at a Michigan paper mill.

Allyson W O'Connor, Ju-Hyeong Park, Marcia L Stanton, Xiaoming Liang, Dallas Shi, Perri C Callaway, R Reid Harvey, Ryan LeBouf, Rachel L Bailey, Ian Hennessee and 14 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Allyson W O'ConnorRespiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Ju-Hyeong ParkRespiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Marcia L StantonRespiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Xiaoming LiangRespiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Dallas ShiDivision of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio, United States of America.ORCID https://orcid.org/0000-0001-8088-6427
Perri C CallawayRespiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
R Reid HarveyRespiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Ryan LeBoufRespiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Rachel L BaileyRespiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Ian HennesseeLaboratory Leadership Service, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Mitsuru TodaMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Jennifer MeeceMarshfield Clinic Research Institute, Marshfield, Wisconsin, United States of America.
Alana SterkelUniversity of Wisconsin-Madison and Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, United States of America.
Suzanne DargleUniversity of Wisconsin-Madison and Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, United States of America.
Olivia BreeUniversity of Wisconsin-Madison and Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, United States of America.
Jeremy OlstadtMarshfield Clinic Research Institute, Marshfield, Wisconsin, United States of America.
Rebecca ReikMichigan Department of Health and Human Services, Lansing, Michigan, United States of America.
Mary Grace StobierskiMichigan Department of Health and Human Services, Lansing, Michigan, United States of America.
Michael SnyderPublic Health Delta & Menominee Counties, Escanaba, Michigan, United States of America.
Robert YinPublic Health Delta & Menominee Counties, Escanaba, Michigan, United States of America.
Marie A de PerioOffice of the Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio, United States of America.
Stella HinesRespiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Jean Cox-GanserRespiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Michigan Blastomycosis Outbreak Investigation Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlastomycosis is a rare, potentially fatal fungal infection caused by inhalation of Blastomyces spores, typically acquired outdoors in the midwestern and eastern United States. In 2023, the largest recorded U.S. blastomycosis outbreak occurred among workers at a paper mill in Michigan's Upper Peninsula. Few data exist on occupational risk factors or indoor exposure to Blastomyces, limiting prevention efforts.

objectivesWe assessed workplace environments and conditions associated with blastomycosis risk through a cross-sectional medical survey and environmental sampling.

methodsDuring April 22-28, 2023, we conducted a voluntary medical survey, including a work and health questionnaire and urine antigen testing, for 603 workers out of approximately 1,000 at the mill. We compared worker characteristics, work locations, and environmental exposures by blastomycosis case status and modeled disease risk using Poisson regression. We tested 533 environmental samples of outdoor soil, indoor surface dust, and raw materials for Blastomyces using polymerase chain reaction and culture-based methods.

resultsTwenty percent of workers were classified as blastomycosis cases based on positive urine antigen testing during the survey, self-reported provider diagnoses, or confirmed or probable case status reported by state or local health departments. Prevalence was highest among workers in paper machine line #1 (27%) and maintenance areas (25%). Adjusted analyses indicated a 40% [Prevalence Ratio (PR): 1.40; 95% confidence interval (CI): 1.00, 1.95] and 53% (PR: 1.53; 95% CI: 1.04, 2.25) higher risk for workers in these locations, respectively, compared to workers working elsewhere. Working in both locations doubled blastomycosis risk. Daily exposure to indoor pooling water was associated with a nearly two-fold higher prevalence of blastomycosis (PR: 1.79; 95% CI: 1.25, 2.57). All indoor and outdoor environmental samples were negative for Blastomyces. DISCUSSION: Blastomycosis was associated with specific indoor work locations and environmental conditions, suggesting the potential for occupational exposure to Blastomyces in indoor industrial settings. These findings may guide future outbreak investigations and occupational prevention strategies.

Indexed as

BlastomycosisDisease OutbreaksOccupational DiseasesOccupational ExposureAdultBlastomycesCross-Sectional StudiesFemaleHumansMaleMichiganMiddle AgedPaperRisk FactorsSurveys and QuestionnairesWorkplace

Identifiers

PMID40986553
PMCPMC12456783

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.